Summary of Purpose
This is a multicenter, randomized, double-blind, placebo-controlled trial aims to assess the effectiveness of repetitive transcranial magnetic stimulation(rTMS) in treating depression after basal ganglia ischemic stroke and to examine whether such effects are related to restoration of white matter integrity.Sixty-six participants will be recruited from three centers and randomized with a 1:1 ratio to receive...Read More →
The following dates are available for this trial. Trial information last updated on 16 January 2018.
|20 Nov 2017||1 May 2017||31 May 2020||31 May 2020||1 Jan 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Zhujiang Hospital Lead
- Lianxu Zhao, M.D